10X Genomics Inc (Class A)

15 sept. 2026, 23:02 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting overall positive market sentiment despite recent declines in manufacturing and rising crude oil inventories.

14 sept. 2026, 23:06 UTC

10X Genomics Inc. shares are lower in after-market trading, aligning with a broader U.S. market decline amid rising crude oil prices due to supply concerns.

11 sept. 2026, 20:08 UTC

10X Genomics Inc. is rising today, supported by positive social media sentiment and strong trading momentum above key moving averages.

10 sept. 2026, 23:26 UTC

10X Genomics shares advanced in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

9 sept. 2026, 19:56 UTC

UBS raised its price target for 10X Genomics to $68, maintaining a Neutral rating. The stock is trading higher amid positive social media discussions.

8 sept. 2026, 20:07 UTC

10X Genomics raises 2026 revenue guidance to $610 million-$630 million, driving shares higher during trading. Analysts express concerns about potential overvaluation.

2 sept. 2026, 20:08 UTC

10X Genomics Inc. shares are higher today, driven by significant gains in the Life Sciences Tools & Services sub-sector. No specific company news was identified.

1 sept. 2026, 20:04 UTC

10X Genomics Inc shares are lower after RBC Capital initiated coverage with a Sector Perform rating and a $70 price target. Rising oil prices add to inflation concerns.

31 aug. 2026, 20:07 UTC

10X Genomics awarded over $4.8 million in damages by jury for patent infringement. Analysts see potential for favorable outcomes, boosting shares higher today.

28 aug. 2026, 23:46 UTC

10X Genomics Inc is trading higher in after-market hours, reflecting positive market performance amid rising Treasury yields and increased rate hike expectations.

26 aug. 2026, 19:36 UTC

10X Genomics Inc shares are lower today, reaching a session low earlier. Broader inflation data may impact Federal Reserve policy decisions.

25 aug. 2026, 23:21 UTC

10X Genomics Inc shares are higher in after-market hours, though no specific news was identified. Market sentiment improved amid a decline in crude oil prices.

24 aug. 2026, 19:26 UTC

10X Genomics Inc shares are lower today amid broader market declines and geopolitical tensions, though the stock remains significantly above its 20-day moving average.

21 aug. 2026, 23:16 UTC

10X Genomics Inc. shares are higher in after-market trading, continuing gains since Friday's close, amid broader cryptocurrency market strength.

20 aug. 2026, 23:16 UTC

10X Genomics Inc. shares traded lower after-market, amid broader market pressure from rising bond yields and concerns over high borrowing costs and geopolitical risks.

19 aug. 2026, 23:06 UTC

10X Genomics Inc shares are higher in after-market trading, reflecting strong momentum above the 20-day moving average and near the top of its one-month range.

18 aug. 2026, 23:31 UTC

10X Genomics Inc shares are higher in after-market trading, maintaining a notable increase while staying above the 20-day moving average. No specific news was identified.

17 aug. 2026, 19:16 UTC

10X Genomics Inc shares are higher today, recovering from an initial dip. The stock remains above its 20-day moving average amid mixed economic indicators.

14 aug. 2026, 20:06 UTC

10X Genomics Inc shares are lower today amid mixed market sentiment following a reported decline in U.S. retail sales for July.

13 aug. 2026, 19:16 UTC

10X Genomics Inc reported Q2 revenue of $151 million, exceeding estimates. Shares are higher as management raises full-year revenue guidance to $620 million.

12 aug. 2026, 19:46 UTC

10X Genomics Inc. shares are lower today, having retraced from an early peak. The stock remains above its 20-day moving average.

11 aug. 2026, 20:06 UTC

10X Genomics Inc. shares are lower today amid routine trading, despite earlier fluctuations and remaining above the 20-day moving average.

10 aug. 2026, 20:03 UTC

10X Genomics shares rise as Piper Sandler and Canaccord Genuity raise price targets to $47.00 and $60.00, respectively, amid increased trading volume.

7 aug. 2026, 23:16 UTC

10X Genomics Inc shares are lower in after-market trading amid a sector decline. Citigroup raised its price target to $50 while maintaining a Neutral rating.

6 aug. 2026, 23:02 UTC

10X Genomics reported a net loss of $17.9 million for Q2, with shares trading lower in after-market hours amid concerns over an operating loss.

5 aug. 2026, 19:26 UTC

10X Genomics Inc shares are lower amid broader market declines. The company reported $150.8 million in revenue last quarter, reflecting a year-on-year decline.

3 aug. 2026, 19:36 UTC

10X Genomics Inc reached a new 52-week high, reflecting strong market activity and positive sentiment in the genomics sector. Shares are higher since Friday's close.

31 iul. 2026, 19:36 UTC

10X Genomics shares are lower today, continuing a decline since Thursday's close. The Russell 2000 Index also reflects broader market weakness.

30 iul. 2026, 17:06 UTC

10X Genomics Inc is higher today, supported by broader market trends and a significant rise since Wednesday's close. The stock peaked intraday with notable gains.

29 iul. 2026, 19:27 UTC

10X Genomics Inc announced a collaboration with Lausanne University Hospital to enhance cancer diagnostics. Shares are higher since Tuesday's close, reflecting positive sentiment.